Literature DB >> 25664012

TLR3 correlated with cervical lymph node metastasis in patients with papillary thyroid cancer.

Dapeng Li1, Runxia Gu2, Xiaoyong Yang1, Chuanxiang Hu1, Yigong Li1, Ming Gao1, Yang Yu1.   

Abstract

Papillary thyroid cancer (PTC) is the most rapidly increasing endocrine malignancy worldwide. Although less aggressive than the majority malignancies, PTC exhibits extensive cervical lymph node metastasis in early stage of PTC. However, the underlying molecular mechanism of this early-metastasis remains unknown. Toll like receptors (TLRs) constitute a crucial component of the innate immune response to bacterial and viral pathogens. Emerging evidence suggests that TLRs play important roles in cancer progression, invasion and immune evasion, whereas whether TLRs have any role in PTC remains to be clarified. In this study, we found that TLR3 was present in both PTC specimen and various thyroid cancer cell lines. Further IHC analysis of 63 PTC patients revealed that TLR3 expression was associated with cervical metastasis, but not correlated with patients' TNM staging, extrathyroidal invasion. In addition, TLR3 promoted migration of K1 cells in vitro. Activation of TLR3 increased cancer stem cell marker and migration promoting CD44 expression in vitro, indicating that TLR3 might promote metastasis of PTC via modulating CD44 expression. Taken together, our data revealed that TLR3 is correlated with cervical metastasis of PTC and might be an essential prognostic indicator and target for PTC metastasis.

Entities:  

Keywords:  CD44; Papillary thyroid cancer (PTC); Toll-like receptor (TLR); metastasis

Year:  2014        PMID: 25664012      PMCID: PMC4307459     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

Review 1.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  Toll-like receptors on tumor cells facilitate evasion of immune surveillance.

Authors:  Bo Huang; Jie Zhao; Hongxing Li; Kai-Li He; Yibang Chen; Shu-Hsia Chen; Lloyd Mayer; Jay C Unkeless; Huabao Xiong
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

3.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

Review 4.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

5.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.

Authors:  Muller Fabbri; Alessio Paone; Federica Calore; Roberta Galli; Eugenio Gaudio; Ramasamy Santhanam; Francesca Lovat; Paolo Fadda; Charlene Mao; Gerard J Nuovo; Nicola Zanesi; Melissa Crawford; Gulcin H Ozer; Dorothee Wernicke; Hansjuerg Alder; Michael A Caligiuri; Patrick Nana-Sinkam; Danilo Perrotti; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 6.  Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

Authors:  Lilly Y W Bourguignon
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 7.  Controversies in primary treatment of low-risk papillary thyroid cancer.

Authors:  Donald S A McLeod; Anna M Sawka; David S Cooper
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

8.  Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

Authors:  Salomé González-Reyes; Laura Marín; Lucía González; Luis O González; José M del Casar; Maria L Lamelas; José M González-Quintana; Francisco J Vizoso
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

9.  TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1.

Authors:  D Peter O'Leary; Lavinia Bhatt; John F Woolley; David R Gough; Jiang H Wang; Thomas G Cotter; H Paul Redmond
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands.

Authors:  Valerie Chew; Jean-Pierre Abastado
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

View more
  7 in total

Review 1.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

2.  Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation.

Authors:  Liang Zhou; Xiaoling Hang; Lei Xie
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

3.  Profile of gene expression of TLR-signaling pathways in colorectal cancer tissues.

Authors:  Martyna Bednarczyk; Małgorzata Muc-Wierzgoń; Katarzyna Walkiewicz; Teresa Kokot; Edyta Fatyga; Urszula Mazurek
Journal:  Int J Immunopathol Pharmacol       Date:  2017-06-19       Impact factor: 3.219

4.  Drinking Hydrogen-Rich Water Alleviates Chemotherapy-Induced Neuropathic Pain Through the Regulation of Gut Microbiota.

Authors:  Naqi Lian; Mengxi Shen; Kai Zhang; Jiacheng Pan; Yi Jiang; Yang Yu; Yonghao Yu
Journal:  J Pain Res       Date:  2021-03-10       Impact factor: 3.133

5.  Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment.

Authors:  Shengwei Han; Wenguang Xu; Zhiyong Wang; Xiaofeng Qi; Yufeng Wang; Yanhong Ni; Hao Shen; Qingang Hu; Wei Han
Journal:  Oncotarget       Date:  2016-06-21

6.  Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.

Authors:  Zhaolan Xiang; Cheng Zhong; Aoshuang Chang; Junjun Ling; Houyu Zhao; Wei Zhou; Xianlu Zhuo
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

7.  Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.

Authors:  Bowen Wang; Haoran Zhao; Shaobin Ni; Beichen Ding
Journal:  J Healthc Eng       Date:  2021-06-30       Impact factor: 2.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.